Risk factors of poor developmental outcome in children with tuberculous meningitis

Caro-Lee Saal1, Priscilla Springer2, James A Seddon2,3

  • 1Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Insights

Neurodevelopmental delay in children with tuberculous meningitis (TBM) is linked to factors like reduced consciousness and brainstem issues. Identifying these predictors aids in early prognostication and supportive care for better outcomes.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neuroscience

Background:

  • Childhood tuberculous meningitis (TBM) frequently results in long-term neurodevelopmental delay.
  • Identifying risk factors for this delay is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess demographic, clinical, laboratory, and neuro-imaging risk factors associated with neurodevelopmental delay in children treated for TBM.

Main Methods:

  • A retrospective cohort study was conducted involving 327 children diagnosed with TBM between 1985 and 2015.
  • Cognitive impairment, defined as moderate-to-severe, was assessed post-treatment.
  • Multivariate analysis examined associations between patient characteristics and poor developmental outcomes.

Main Results:

  • Of 327 patients, 71 (21.7%) experienced poor developmental outcomes.
  • Decreased level of consciousness, brainstem dysfunction, and radiological infarction were significant predictors of poor outcomes.
  • Left hemispherical and bilateral strokes were also associated with adverse developmental results.

Conclusions:

  • Neurological signs and radiological infarct characteristics are key predictors of poor neurodevelopmental outcomes in childhood TBM.
  • Early identification of these predictors enables more accurate prognostication.
  • Prompt initiation of supportive and rehabilitative measures can improve long-term cognitive function.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
410
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225